Clarus Therapeutics Holdings, Inc.

Delisted

CIK 1817944fmd_11SNH82AX3JH77G13FXXGEVXC2Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2020 to Jun 30, 2022, 10 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.